There is still a place for significance testing in clinical trials.
作者信息
Cook Jonathan A, Fergusson Dean A, Ford Ian, Gonen Mithat, Kimmelman Jonathan, Korn Edward L, Begg Colin B
机构信息
1 Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK.
2 Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
出版信息
Clin Trials. 2019 Jun;16(3):223-224. doi: 10.1177/1740774519846504. Epub 2019 May 9.
Abstract
摘要
相似文献
1
There is still a place for significance testing in clinical trials.显著性检验在临床试验中仍有一席之地。
Clin Trials. 2019 Jun;16(3):223-224. doi: 10.1177/1740774519846504. Epub 2019 May 9.
2
What should be the role of homogeneity testing in adaptive trials?在适应性试验中，同质性检验应发挥什么作用？
Pharm Stat. 2009 Jan-Mar;8(1):1-4. doi: 10.1002/pst.342.
3
Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: emerging statistical issues in the conduct and monitoring of clinical trials.宾夕法尼亚大学临床试验统计问题年度会议论文集：临床试验实施与监测中的新出现的统计问题
Clin Trials. 2012 Dec;9(6):669-70. doi: 10.1177/1740774512463178.
4
Interpreting and reporting clinical trials with results of borderline significance.解读并报告具有临界显著性结果的临床试验。
BMJ. 2011 Jul 4;343:d3340. doi: 10.1136/bmj.d3340.
5
Estimands in diabetes clinical trials.糖尿病临床试验中的估计量。
Lancet Diabetes Endocrinol. 2020 Mar;8(3):181-183. doi: 10.1016/S2213-8587(19)30407-3. Epub 2020 Jan 21.
6
Subgroup analysis in clinical trials.临床试验中的亚组分析。
Med J Aust. 2004 Mar 15;180(6):289-91. doi: 10.5694/j.1326-5377.2004.tb05928.x.
7
Pitfalls in the interpretation of studies: III.研究解读中的陷阱：III.
J R Soc Med. 1995 May;88(5):241-3.
8
Proceedings of the University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs?宾夕法尼亚大学第九届临床试验统计问题年度会议论文集：适应性临床试验设计进展如何？
Clin Trials. 2017 Oct;14(5):415-416. doi: 10.1177/1740774517723606. Epub 2017 Aug 4.
9
Statistics and logistics: Design of Ebola vaccine trials in West Africa.统计学与后勤保障：西非埃博拉疫苗试验的设计
Clin Trials. 2016 Feb;13(1):87-91. doi: 10.1177/1740774515620612. Epub 2016 Jan 14.
10
Clinical versus statistical considerations in the design and analysis of clinical research.
J Clin Epidemiol. 1998 Apr;51(4):305-7. doi: 10.1016/s0895-4356(98)00006-7.
引用本文的文献
1
Using non-inferiority test of proportions in design of randomized non-inferiority trials with time-to-event endpoint with a focus on low-event-rate setting.在具有事件发生时间终点的随机非劣效性试验设计中，使用比例的非劣效性检验，重点关注低事件率情况。
Clin Trials. 2025 Apr;22(2):131-141. doi: 10.1177/17407745241284786. Epub 2024 Oct 12.
2
Statistical significance and its critics: practicing damaging science, or damaging scientific practice?统计学显著性及其批评者：是在践行有害科学，还是在损害科学实践？
Synthese. 2022;200(3):220. doi: 10.1007/s11229-022-03692-0. Epub 2022 May 12.
3
Current practice in analysing and reporting binary outcome data-a review of randomised controlled trial reports.目前分析和报告二项结局数据的实践——对随机对照试验报告的综述。
BMC Med. 2020 Jun 8;18(1):147. doi: 10.1186/s12916-020-01598-7.
4
In Defense of Values.为价值观辩护。
JNCI Cancer Spectr. 2020 Feb 26;4(2):pkaa012. doi: 10.1093/jncics/pkaa012. eCollection 2020 Apr.
5
'Not clinically effective but cost-effective' - paradoxical conclusions in randomised controlled trials with 'doubly null' results: a cross-sectional study.“无临床疗效但具有成本效益”——具有“双重无效”结果的随机对照试验中的矛盾结论：一项横断面研究。
BMJ Open. 2020 Jan 9;10(1):e029596. doi: 10.1136/bmjopen-2019-029596.
6
Methods for Accommodating Nonproportional Hazards in Clinical Trials: Ready for the Primary Analysis?临床试验中处理非比例风险的方法：准备好进行初步分析了吗？
J Clin Oncol. 2019 Dec 10;37(35):3455-3459. doi: 10.1200/JCO.19.01681. Epub 2019 Oct 24.
本文引用的文献
1
Scientists rise up against statistical significance.科学家们奋起反对统计显著性。
Nature. 2019 Mar;567(7748):305-307. doi: 10.1038/d41586-019-00857-9.
2
DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.DELTA 指南：选择目标差值以及进行和报告随机对照试验的样本量计算。
BMJ. 2018 Nov 5;363:k3750. doi: 10.1136/bmj.k3750.
3
Proceedings of the University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs?宾夕法尼亚大学第九届临床试验统计问题年度会议论文集：适应性临床试验设计进展如何？
Clin Trials. 2017 Oct;14(5):415-416. doi: 10.1177/1740774517723606. Epub 2017 Aug 4.
4
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.主要结局为统计学无显著性结果的随机对照试验的报告和解释。
JAMA. 2010 May 26;303(20):2058-64. doi: 10.1001/jama.2010.651.
Zotero 插件